氨氯地平阿托伐他汀钙片治疗高血压合并冠心病的疗效分析  被引量:6

Amlodipine atorvastatin calcium tablet in the treatment of hypertension complicated with coronary heart disease

在线阅读下载全文

作  者:徐姝[1] 张彦红[1] 腾旭[1] 李阳 杨晓旭[1] 刘艳 Xu Shu;Zhang Yanhong;Teng Xu;Li Yang;Yang Xiaoxu;Liu Yan(The Second Affiliated Hospital of Shenyang Medical College Dry Clinic,Shenyang,Liaoning,110002,China)

机构地区:[1]沈阳医学院附属第二医院干诊科,辽宁沈阳110002

出  处:《当代医学》2019年第5期79-80,共2页Contemporary Medicine

摘  要:目的分析氨氯地平阿托伐他汀钙片治疗高血压合并冠心病患者的疗效。方法选取本院在2016年3月至2017年5月期间收治的高血压合并冠心病患者128例予以分组,选择抽签法的分组方式将其分为对照组和治疗组,各64例,对照组使用硝苯地平缓释片治疗,治疗组使用氨氯地平阿托伐他汀钙片治疗,将治疗效果和不良反应发生情况作为观察指标。结果对照组与治疗组的治疗总有效率各自为81.25%、93.75%,组间进行比较,治疗组高于对照组,差异具有统计学意义(P<0.05);治疗组的不良反应发生率为7.81%,与对照组的不良反应发生率26.56%比较,两组差异具有统计学意义(P<0.05)。结论氨氯地平阿托伐他汀钙片治疗高血压合并冠心病具有效果良好,安全性高等优势,值得作为理想治疗药物在临床中大力推广。Objective To analyze the efficacy of atorvastatin calcium tablet in the treatment of hypertension with coronary heart disease.Methods 128 patients with hypertension combined with coronary heart disease who were admitted to our hospital from March 2016 to May 2017 were selected.They were divided into control group and treatment group by grouping by lottery,and 64 cases were compared.The group was treated with nifedipine sustained-release tablets,and the treatment group was treated with atorvastatin calcium tablets of amlodipine.The treatment effects and occurrence of adverse reactions were taken as the observation indicators.Results The total effective rate of treatment in the control group and the treatment group was 81.25%and 93.75%respectively.The comparison between the two groups was significant in the treatment group and the control group(P<0.05).The incidence of adverse reactions in the treatment group was 7.81%,which compared with the control group's adverse reaction rate of 26.56%,there was a statistical difference between the two groups(P<0.05).Conclusion Amlodipine atorvastatin calcium tablet has the advantages of good effect and high safety in the treatment of hypertension combined with coronary heart disease.It is worthy of being promoted as an ideal therapeutic drug in clinical practice.

关 键 词:冠心病 高血压 氨氯地平阿托伐他汀钙片 安全性 

分 类 号:R544.1[医药卫生—心血管疾病] R541.4[医药卫生—内科学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象